Obese patients wait longer for kidney transplants, research suggests

December 19, 2007

New research from Johns Hopkins specialists suggests that obese kidney disease patients face not only the usual long odds of a tissue match and organ rejection, but also are significantly less likely than normal-weight people to receive a kidney transplant at all.

The Johns Hopkins study results, to be published online this Wednesday in the Journal of the American Society of Nephrology, reveal that morbidly obese patients (those who on average weigh 100 pounds more than their ideal weight) are on the transplant waiting list for a median of five years - two years more than the median wait time for a patient of normal weight.

Because patients tend to get sicker the longer they wait on dialysis, obese patients are 44 percent less likely than normal-weight patients to ever receive a kidney transplant, the researchers report. Each year, 8 percent of the patients on the list die waiting for a kidney.

Johns Hopkins transplant surgeon Dorry Segev, M.D., who led the study, suggests that obese patients might be turned down, sometimes multiple times, because of the added cost and poorer outcome associated with transplants in overweight patients.

"Being overweight should not be a disqualifying and discriminating factor against these patients," Segev says.

He adds that at Johns Hopkins, the rate at which overweight, severely obese, and morbidly obese patients are listed and receive transplants is much higher than the national average. As a result, the waiting times for obese patients are not significantly different.

"Patients understandably believe that being placed on the transplant waiting list is an implicit promise of fair, unbiased treatment under a transparent allocation scheme," Segev says. "Unfortunately, the system that has been established nationally may not be living up to that promise."

The study's findings may be explained, he says, by economic pressures as well as medical ones. He notes that Medicare - the principal insurer for kidney transplants - pays a set amount for the operation regardless of a patient's overall health, difficulty of the operation, length of stay, postoperative care and complications, all of which may increase substantially with obese patients. Transplant centers, therefore, may be under pressure to avoid operating on these individuals.

In addition, Segev says, centers with lower surgical survival rates overall risk losing Medicare funding.

The researchers analyzed data from 132,353 men and women with kidney disease who were on the United Network for Organ Sharing (UNOS) deceased donor kidney transplantation list from 1995 to 2006 in the United States.

Patients' weight was rated using the body mass index (BMI) scale - weight in kilograms divided by height in meters squared. A normal BMI is 18.5. Overweight is 25 (25 to 30), obese is 30 to 35 severely obese is 35 to 40 and morbidly obese is 40 to 60.

Of the group analyzed, 48,349 were of normal weight, 45,411 were overweight, 25,509 were obese, 9,479 were severely obese and 3,605 were morbidly obese.

After adjusting for additional health factors that might affect a person's eligibility for transplantation (such as blood type, age, type of kidney disease, diabetes and heart disease), the researchers found that the likelihood of receiving a transplant, when compared to patients with a normal weight, decreases by 4 percent for overweight patients, 7 percent for obese patients, 28 percent for severely obese patients and 44 percent for morbidly obese patients.

Segev says the number of overweight patients joining the UNOS waiting list has gone up markedly in the last decade as the rate of obesity has grown in the U.S. population. From 1995 to 2005, the number of severely obese patients added to the list increased by 310 percent, and the number of morbidly obese patients added to the list increased by 247 percent. In contrast, the number of people of normal weight added to the list increased by only 33 percent.

"The transplant community needs to develop appropriate guidelines stipulating which patients are appropriate for transplantation and to do our best to treat them equally," says Segev. "Similarly, both outcomes evaluation and reimbursement need to reflect the varying difficulty of care for these patients in order to remove the disincentives of taking on challenging cases."

A study by Johns Hopkins surgeon Anne Lidor, M.D., is currently examining whether overweight transplants patients should be recommended for gastric bypass surgery at the time they're first listed.

"This would improve survival while the patient is waiting for a kidney and also improve survival after receiving the kidney, which should eliminate any potential bias for receiving a kidney in a timely fashion," says Segev.
-end-
Additional Johns Hopkins researchers who contributed to this paper include Robert A. Montgomery, M.D., Ph.D.; Christopher E. Simpkins, M.D.; Jayme E. Locke, M.D.; and Daniel S. Warren, Ph.D., of the Department of Surgery; and Richard E. Thompson, Ph.D., of the Bloomberg School of Public Health.

Johns Hopkins Medicine

Related Kidney Disease Articles from Brightsurf:

Waistline matters in kidney disease
Does fat matter in kidney disease? The investigators found that all measures of higher abdominal fat content (including visceral fat, liver fat, or subcutaneous fat) and slower walk times were associated with increased levels of cardiometabolic risk factors in adults with non-dialysis dependent kidney disease.

Reducing urinary protein for patients with rare kidney disease slows kidney decline
New findings show that reducing the amount of protein in the urine of patients with focal segmental glomerulosclerosis can significantly slow declines in kidney function and extend time before patients' kidneys fail.

Antioxidant agent may prevent chronic kidney disease and Parkinson's disease
Researchers from Osaka University developed a novel dietary silicon-based antioxidant agent with renoprotective and neuroprotective effects.

Acute kidney injury and end stage kidney disease in severe COVID-19
Many COVID-19 patients experience hematuria, proteinuria and elevated serum creatinine concentration early in the course of the disease.

Genes tell a story about diabetic kidney disease
Studying Finnish genes leads to unique revelations about the development of a serious complication of diabetes, and informs an ongoing genomic study of a Singaporean cohort as part of Singapore's Diabetes Study in Nephropathy and other Microvascular Complications (DYNAMO).

New study provides insight into chronic kidney disease
Researchers have further analyzed a known signaling pathway they believe brings them one step closer to understanding the complex physiology of patients with chronic kidney disease (CKD), which might provide a path to new treatment options.

Predicting risk of chronic kidney disease
Data from about 5 million people (with and without diabetes) in 28 countries were used to develop equations to help identify people at increased five-year risk of chronic kidney disease, defined as reduced estimated glomerular filtration rate (eGFR).

A healthy diet may help prevent kidney disease
In an analysis of published studies, a healthy dietary pattern was associated with a 30% lower incidence of chronic kidney disease.

Is kidney failure a man's disease?
A new analysis of the ERA-EDTA Registry [1] reveals a striking gender difference in the incidence and prevalence of end-stage renal disease.

Chronic kidney disease: Everyone's concern
850 million people worldwide are affected by kidney disease. This worrying figure was published last June.

Read More: Kidney Disease News and Kidney Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.